XBiotech

$14.08 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About XBiotech

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies for treating a variety of diseases, such as cancer, vascular disease, inflammatory skin disease, and diabetes.

Stock Analysis

last close $14.08
1-mo return -5.8%
3-mo return -11.4%
avg daily vol. 83.72T
52-week high 17.88
52-week low 12.2
market cap. $401M
forward pe -
annual div. -
roe -3.5%
ltg forecast -
dividend yield -
annual rev. $25M
inst own. 14.5%
baraka

Subscribe now for daily local and international financial news

Subscribe